Aubrai Launches as Onchain AI Scientist to Advance Longevity Research

Quick Summary: 

• Aubrai, co-developed by VitaDAO and Bio Protocol, merges AI with blockchain to accelerate longevity science.
• Hypotheses generated are hashed on Base via Proof-of-Invention, creating an immutable trail of scientific progress.
• The $AUBRAI token funds research, governs experiments and monetizes validated data as onchain knowledge assets.

Aubrai, a decentralized AI agent co-developed by VitaDAO and Bio Protocol, has been unveiled as a blockchain-powered co-scientist designed to accelerate longevity research. Trained on unpublished lab data from renowned gerontologist Aubrey de Grey and enriched by global researcher contributions, Aubrai merges artificial intelligence with onchain infrastructure to validate hypotheses, design lab experiments and secure sensitive data.

Breaking Web2 Barriers in Scientific AI

Unlike Web2-based scientific AI systems from Google and OpenAI, which remain siloed and disconnected from collective funding and coordination, Aubrai integrates directly with blockchain. Through its Proof-of-Invention (POI) system, valid hypotheses are hashed on Base, creating an immutable record of scientific progress while ensuring credit flows back to early contributors.

The agent can be prompted directly on X and is currently in Private Beta via the Aubrai Researcher Terminal, with expedited access for verified researchers. The system enables decentralized funding through $AUBRAI trading fees and plans to tokenize validated research outputs as onchain knowledge assets known as IP-Tokens.

Central to Aubrai’s development is training on LEV Foundation’s Robust Mouse Rejuvenation (RMR2) study, a project exploring lifespan extension therapies in mice. If successful, the initiative could mark a pivotal moment in ageing science by proving the effectiveness of multi-target rejuvenation strategies.

The $AUBRAI token, available on Base via Bio Launchpad, grants holders governance rights over research funding and access to potential revenue streams from pharmaceutical insights, compounds and knowledge monetization. This positions Aubrai as not only a scientific tool but also a decentralized ecosystem where blockchain, AI and longevity research converge.

Web3 Expands Into Digital Advertising

In parallel, Alkimi has announced a partnership with the Sui blockchain to migrate its entire digital advertising supply chain onchain. The collaboration leverages Sui’s high-performance tech stack, including Walrus, Nautilus, and Seal, while integrating Alkimi’s decentralized ad infrastructure. The move signals a broader Web3 shift, where verification, execution, and monetization of ads are handled transparently and efficiently through blockchain.